PhaseRx, Inc. Cm St Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PZRXQ and buy or sell other stocks, ETFs, and their options commission-free!About PZRXQ
PhaseRx, Inc. operates as a bio pharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. Its product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency, argininosuccinate lyase deficiency and argininosuccinate synthetase deficiency.
CEORobert W. Overell, PhD
CEORobert W. Overell, PhD
Employees21
Employees21
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2006
Founded2006
Employees21
Employees21
PZRXQ Key Statistics
Market cap1.17K
Market cap1.17K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 1.17K, PhaseRx, Inc. Cm St Common Stock(PZRXQ) trades at $0.00.
On 2026-03-14, PhaseRx, Inc. Cm St Common Stock(PZRXQ) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.